CDH1 and neoplasm: In addition to its known function as a tumor suppressor [32], Foxo3a has been shown to inhibit HIF-1α transcriptional activity by competing for p300 binding during vascular development [22], and to suppress EMT, in part, through the regulation of E-cadherin expression [33–35].